Chemotherapy optimization aims to improve the safety and efficacy of cancer chemotherapy treatments while reducing side effects. The session "Chemotherapy Optimization" highlights methods to individualize chemotherapy regimens, enhance patient outcomes, and combine new strategies with conventional therapies.".
Optimization of chemotherapy is the choice of correct drug, dose, and timing according to the tumor type, stage, molecular features, and patient-specific variables like age, comorbidities, and genetic makeup. Pharmacogenomics, biomarker-directed therapy, and therapeutic drug monitoring advance the ability of clinicians to forecast response to treatment, minimize toxicity, and avoid drug resistance.
The session discusses combination therapies, dose-adjustment strategies, and integration with targeted therapies or immunotherapies to enhance effectiveness. Innovative methods like drug delivery systems, nanomedicine, and real-time monitoring of circulating tumor markers are offering possibilities for precision dosing and adaptive treatment paradigms. Supportive care interventions are also important in managing toxicities, enhancing quality of life, and ensuring therapy adherence.
Participants will learn about evidence-based strategies, technology innovations, and clinical uses for maximizing chemotherapy. This session highlights the significance of data-driven, tailored strategies to improve therapeutic results, minimize side effects, and promote contemporary oncology practice through precision chemotherapy
Welcome to the Cancer and Oncology Conference 2026, where global researchers, clinicians, and academics meet to share advances in cancer biology, precision medicine, diagnostics, therapies, and global solutions for patient care.
